ThinkBio.Ai® and UST Collaborate to Accelerate AI Transformation in Life Sciences
Mumbai: UST, a leading digital transformation solutions company, has partnered with ThinkBio.Ai®, an AI-powered solutions provider for biopharmaceutical and healthcare organizations. This strategic partnership aims to deliver transformative solutions that accelerate AI transformation journeys and improve outcomes for biopharma and healthcare organizations worldwide. By combining UST’s expertise in digital transformation with ThinkBio.Ai®’s innovative AI-powered R&D capabilities, the companies will drive innovation and deliver measurable impact across the research and development value chain.
Advancing Healthcare Innovation
ThinkBio.Ai® has developed a suite of AI-powered solutions to address critical challenges across pharma and biotech preclinical and clinical R&D pipelines. These solutions include data-driven strategies to identify optimal treatments, salvaging failed drugs, and improving clinical trial success through biomarker-driven patient stratification and digital twin-enabled trial matching. ThinkBio.Ai®’s AI-enhanced Research Co-pilot (R-COP) utilizes AI to extend Laboratory Information Management System (LIMS) capabilities, transforming routine processes into dynamic, insight-driven research operations.
Partnership Goals
The partnership will enable UST to leverage ThinkBio.Ai®’s AI-powered R&D transformation solutions, integrating them with UST’s strengths in digital transformation and Gen AI across life sciences.
Pradeep Palazhi, Founder and CEO of ThinkBio.Ai®, said, “Together, we will build custom ecosystems to help clients and partners stay ahead in a well-regulated, dynamic, and competitive landscape.”
Anu Koshy, Life Science cluster leader at UST, added, “This strategic collaboration will drive innovation, accelerate time-to-value, and deliver measurable impact across the research and development value chain for our customers.”
